| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.1 (Beat by $0.03) |
| EPS GAAP Actual | $0.1 (Beat by $0.03) |
| Revenue Actual | $0.155431B |
| Revenue Surprise | Beat by $155.431M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.11475 |
| EPS GAAP Estimate | $-0.11475 |
| Revenue Estimate | $0.113095B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.099 | -0.064 | 0.155431B | 29.73% | 4.97M |
| FQ2 2025 (Jun 2025) | 0.02 | 0.02 | 0.151296B | 7.42% | 151.3M |
| FQ1 2025 (Mar 2025) | -0.023 | -0.023 | 0.143432B | 3.64% | 143.43M |
| FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 0.134906B | 1.7% | 134.91M |
| FQ3 2024 (Sep 2024) | -0.35 | -0.35 | 0.109217B | -4.64% | 109.22M |
| FQ2 2024 (Jun 2024) | 0.131 | 0.131 | 0.140073B | -18.4% | 140.07M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0.138204B | -30.94% | 138.2M |
| FQ4 2023 (Dec 2023) | -0.0731 | -0.0731 | 0.132613B | -76.19% | 132.61M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.11475
Consensus Revenue Estimates
0.113095B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.14954 | -- | 0.12831 | 0.17161 | 1 |
| FQ3 2027 (Sep 2027) | -0.052563 | -- | -0.052563 | -0.052563 | 1 |
| FQ2 2027 (Jun 2027) | 0.18644 | -- | 0.18644 | 0.18644 | 1 |
| FQ1 2027 (Mar 2027) | 0.22078 | -- | 0.22078 | 0.22078 | 1 |
| FQ4 2026 (Oct 2026) | -0.17383 | -- | -0.19776 | -0.14661 | 0 |
| FQ3 2026 (Jul 2026) | 0.13093 | 24.39 | 0.11042 | 0.14896 | 0 |
| FQ2 2026 (Jun 2026) | 0.065563 | 69.49 | 0.05626717 | 0.07562065 | 1 |
| FQ1 2026 (Mar 2026) | 0.025499 | 190.2 | 0.02188363 | 0.02941066 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.16B | -- | 0.14B | 0.18B | 1 |
| FQ3 2027 (Sep 2027) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ2 2027 (Jun 2027) | 0.17B | -- | 0.17B | 0.17B | 1 |
| FQ1 2027 (Mar 2027) | 0.16B | -- | 0.16B | 0.16B | 1 |
| FQ4 2026 (Oct 2026) | 0.11B | -- | 0.1B | 0.13B | 2 |
| FQ3 2026 (Jul 2026) | 0.17B | 6.51 | 0.15B | 0.18B | 2 |
| FQ2 2026 (Jun 2026) | 0.16B | 4.25 | 0.14B | 0.18B | 2 |
| FQ1 2026 (Mar 2026) | 0.15B | 3.15 | 0.13B | 0.17B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.163 | 0.099 | -0.064 | -64.65% |
| FQ2 2025 (Jun 2025) | 0.02 | 0.02 | 100% | |
| FQ1 2025 (Mar 2025) | -0.023 | -0.023 | 100% | |
| FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 100% | |
| FQ3 2024 (Sep 2024) | -0.35 | -0.35 | 100% | |
| FQ2 2024 (Jun 2024) | 0.131 | 0.131 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | -0.0731 | -0.0731 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.15B | $0.16B | $4.97M | 3.2% |
| FQ2 2025 (Jun 2025) | $0B | $0.15B | $151.3M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.14B | $143.43M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.13B | $134.91M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.11B | $109.22M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.14B | $140.07M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.14B | $138.2M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.13B | $132.61M | 100% |